Gastroesophageal Junction Carcinoma — Trials

Gastroesophageal Junction Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

706 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 231
Recruiting: 125
Ph III recruiting: 18
Growth YoY: +44.2%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (86)

clinicaltrialsPublishedShowing 51–51 of 51 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03857737	Endoscopic Submucosal Dissection Versus Surgery in the Treatment of Early Gastric Cancer	not yet recruiting	N/A	300	Peking University Third HospitalOTHER	1	Feb 28, 2019	clinicaltrials